| Literature DB >> 30866913 |
Kuang Ming Kuo1, Paul C Talley2, Chi Hsien Huang3,4,5,6, Liang Chih Cheng1,7.
Abstract
BACKGROUND: Medications are frequently used for treating schizophrenia, however, anti-psychotic drug use is known to lead to cases of pneumonia. The purpose of our study is to build a model for predicting hospital-acquired pneumonia among schizophrenic patients by adopting machine learning techniques.Entities:
Keywords: Clozapine; Machine learning; Pneumonia; Risk factors; Schizophrenia
Mesh:
Substances:
Year: 2019 PMID: 30866913 PMCID: PMC6417112 DOI: 10.1186/s12911-019-0792-1
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Operational definition of variables
| Variables | Measurement | Definition | |
|---|---|---|---|
| Dependent | Pneumonia | Discrete | Does the infection patient acquire pneumonia during hospitalization? Yes or No. |
| Independent | Gender | Discrete | Gender of the patients, Male or Female. |
| Age | Continuous | Age (in years) during hospitalization | |
| Clozapine use | Discrete | Have taken clozapine? Yes or No | |
| Drug-drug interaction | Discrete | Has the patient taken Clozapine with Fluoxetine/Carpine/Depatec at the same time? | |
| Coughing | Discrete | Does the patient have coughs? Yes or No. | |
| Dosage | Continuous | The amount of medication taken by patients. | |
| Duration of medication | Continuous | The total days patients took Clozapine. | |
| Change of leukocyte count | Continuous | The difference of leukocyte count between start hospitalization and reported as infection. | |
| Change of neutrophil count | Continuous | The difference of neutrophil count between start hospitalization and reported as infection. | |
| Change of blood sugar level | Continuous | The difference of blood sugar between start hospitalization and reported as infection. | |
| Change of weight | Continuous | The difference of body weight between start hospitalization and reported as infection. | |
Model parameter settings
| Method | Parameter | Best parameter setting |
|---|---|---|
| CART | cp | 0.005952381 |
| C5.0 | model | rules |
| winnow | FALSE | |
| trials | 67 | |
| KNN | k | 27 |
| Naïve Bayes | fL | 0 |
| usekernel | FALSE | |
| adjust | 1 | |
| Random Forest | mtry | 12 |
| Support Vector Machine | sigma | 0.1786673 |
| C | 581.883 |
Descriptive statistics for patients with/without pneumonia
| Variable | Patients with pneumonia ( | Patients without pneumonia ( | ||
|---|---|---|---|---|
| Range | Summary statistics | Range | Summary statistics | |
| Gender | Male/Female | Male: 77, Female: 29 | Male/Female | Male: 53, Female: 26 |
| Age | 26~82 | M = 52.51, SD = 12.33 | 22~81 | M = 51.28, SD = 14.66 |
| Clozapine use | Yes/No | Yes = 50, No = 56 | Yes/No | Yes = 5, No = 74 |
| Drug-drug interaction | Yes/No | Yes = 15, No = 91 | Yes/No | Yes = 1, No = 78 |
| Coughing | Yes/No | Yes = 29, No = 77 | Yes/No | Yes = 16, No = 63 |
| Dosage | 0~800 | M = 113.42, SD = 161.09 | 0~350 | M = 10.13, SD = 47.62 |
| Duration of medication | 0~377 | M = 47.93, SD = 82.41 | 0~295 | M = 8.61, SD = 42.77 |
| Change of leukocyte count | − 5200~5021 | M = 136.60, SD = 1896.11 | − 8840~5500 | M = 658.63, SD = 1996.90 |
| Change of neutrophil count | −29.4~27.3 | M = −1.04, SD = 9.16 | −18.6~32.6 | M = 3.84, SD = 9.35 |
| Change of blood sugar level | − 318~153 | M = −0.15, SD = 40.12 | − 49~133 | M = 0.29, SD = 21.52 |
| Change of weight | −16.5~12.5 | M = 0.82, SD = 3.96 | −11.5~13 | M = 1.05, SD = 4.53 |
Performance evaluation of models employed
| Sample | Method | Accuracy(SD) | AUC(SD) | Sensitivity(SD) | Specificity(SD) | Kappa(SD) |
|---|---|---|---|---|---|---|
| Train | CART | 0.804(0.089) | 0.851(0.074) | 0.739(0.094) | 0.851(0.106) | 0.597(0.180) |
| C5.0 | 0.912(0.033) | 0.971(0.018) | 0.868(0.047) | 0.942(0.030) | 0.819(0.068) | |
| KNN | 0.645(0.083) | 0.696(0.066) | 0.628(0.127) | 0.657(0.130) | 0.282(0.162) | |
| NB | 0.675(0.095) | 0.798(0.094) | 0.868(0.096) | 0.544(0.098) | 0.376(0.178) | |
| RF | 0.917(0.017) | 0.971(0.016) | 0.891(0.048) | 0.937(0.032) | 0.831(0.035) | |
| SVM | 0.871(0.030) | 0.936(0.030) | 0.832(0.077) | 0.923(0.043) | 0.733(0.062) | |
| LGR | 0.670(0.084) | 0.762(0.083) | 0.621(0.076) | 0.706(0.139) | 0.330(0.160) | |
| Test | CART | 0.830 | 0.880 | 0.904 | 0.732 | 0.648 |
| C5.0 | 0.945 | 0.993 | 0.989 | 0.887 | 0.887 | |
| KNN | 0.667 | 0.701 | 0.745 | 0.563 | 0.312 | |
| NB | 0.733 | 0.831 | 0.628 | 0.873 | 0.479 | |
| RF | 0.927 | 0.994 | 1.000 | 0.831 | 0.849 | |
| SVM | 0.897 | 0.953 | 0.968 | 0.803 | 0.786 | |
| LGR | 0.739 | 0.823 | 0.798 | 0.662 | 0.464 |
Note: SD denotes standard deviation
Ranking of investigated variables according to gain ratios
| Variables | Information gain | Ranking | Gain ratio | Ranking |
|---|---|---|---|---|
| Dosage | 0.124 | 1 | 0.217 | 1 |
| Clozapine use | 0.093 | 2 | 0.150 | 2 |
| Duration of medication | 0.072 | 3 | 0.115 | 3 |
| Change of neutrophil count | 0.046 | 4 | 0.068 | 6 |
| Change of leukocyte count | 0.039 | 5 | 0.107 | 4 |
| Drug-drug interaction | 0.028 | 6 | 0.076 | 5 |